DK1877102T3 - Tab-molekyler - Google Patents
Tab-molekylerInfo
- Publication number
- DK1877102T3 DK1877102T3 DK06769868.8T DK06769868T DK1877102T3 DK 1877102 T3 DK1877102 T3 DK 1877102T3 DK 06769868 T DK06769868 T DK 06769868T DK 1877102 T3 DK1877102 T3 DK 1877102T3
- Authority
- DK
- Denmark
- Prior art keywords
- tab
- molecules
- tab molecules
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
- A61K47/6899—Antibody-Directed Enzyme Prodrug Therapy [ADEPT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medical Informatics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67572805P | 2005-04-28 | 2005-04-28 | |
PCT/US2006/015082 WO2006116076A2 (en) | 2005-04-28 | 2006-04-21 | Tab molecules |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1877102T3 true DK1877102T3 (da) | 2014-07-21 |
Family
ID=37057114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06769868.8T DK1877102T3 (da) | 2005-04-28 | 2006-04-21 | Tab-molekyler |
Country Status (5)
Country | Link |
---|---|
US (2) | US8101728B2 (da) |
EP (1) | EP1877102B1 (da) |
JP (1) | JP5330826B2 (da) |
DK (1) | DK1877102T3 (da) |
WO (1) | WO2006116076A2 (da) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2010268690B2 (en) * | 2009-07-03 | 2011-11-10 | Avipep Pty Ltd | Immuno-conjugates and methods for producing them |
US9315581B2 (en) | 2009-12-23 | 2016-04-19 | A Vipep Pty Limited | Immuno-conjugates and methods for producing them |
CA2860835A1 (en) * | 2012-01-09 | 2013-07-18 | General Electric Company | Methods of stabilizing total organic carbon (toc) levels in non-acidified standards for toc analyzers at room temperature |
US11400145B2 (en) * | 2015-11-27 | 2022-08-02 | Cartherics Pty. Ltd. | Genetically modified cells and uses thereof |
EP3755370A4 (en) * | 2018-02-23 | 2021-12-01 | Cartherics Pty. Ltd. | T-CELL DISEASE TREATMENT TARGETED FOR DAY-72 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2209701A (en) | 1938-03-08 | 1940-07-30 | Andrew J Mcgann | Device for cutting or scoring necks of bottles |
US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
US4711845A (en) | 1984-08-31 | 1987-12-08 | Cetus Corporation | Portable temperature-sensitive control cassette |
EP0196864A3 (en) | 1985-03-25 | 1988-03-23 | Cetus Corporation | Alkaline phosphatase-mediated processing and secretion of recombinant proteins, dna sequences for use therein and cells transformed using such sequences |
US4975278A (en) | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
US5773435A (en) | 1987-08-04 | 1998-06-30 | Bristol-Myers Squibb Company | Prodrugs for β-lactamase and uses thereof |
US5766883A (en) | 1989-04-29 | 1998-06-16 | Delta Biotechnology Limited | Polypeptides |
US6495137B1 (en) * | 1990-04-19 | 2002-12-17 | The Dow Chemical Company | Humanized anti-tag-72 monoclonal antibodies using human subgroup 4 kappa light chains |
US5843440A (en) | 1990-10-03 | 1998-12-01 | Redcell Canada, Inc. | Cellular and serum protein anchors for modulating pharmacokinetics |
ES2174915T3 (es) | 1993-11-10 | 2002-11-16 | Enzon Inc | Productos de conjugacion mejorados de un interferon con un polimero. |
US6132722A (en) * | 1997-05-07 | 2000-10-17 | Bristol-Myers Squibb Company | Recombinant antibody-enzyme fusion proteins |
WO1999019362A1 (en) | 1997-10-15 | 1999-04-22 | Medarex, Inc. | BISPECIFIC MOLECULES DIRECTED TO TUMOR ASSOCIATED GLYCOPROTEIN-72 AND Fc RECEPTOR |
IL138021A0 (en) * | 1998-02-25 | 2001-10-31 | Dow Chemical Co | High affinity humanized anti-tag-72 monoclonal antibodies |
US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US6216375B1 (en) | 1999-02-08 | 2001-04-17 | Griffin Group, Inc. | Sign decoration system |
TWI310684B (en) | 2000-03-27 | 2009-06-11 | Bristol Myers Squibb Co | Synergistic pharmaceutical kits for treating cancer |
US20030104591A1 (en) | 2000-12-14 | 2003-06-05 | Murray Christopher J. | Methods and compositions for grafting functional loops into a protein |
US20030147874A1 (en) | 2000-12-14 | 2003-08-07 | Volker Schellenberger | Targeted enzyme prodrug therapy |
US20030049689A1 (en) | 2000-12-14 | 2003-03-13 | Cynthia Edwards | Multifunctional polypeptides |
US20030100467A1 (en) | 2001-09-12 | 2003-05-29 | Wolfgang Aehle | Binding phenol oxidizing enzyme-peptide complexes |
US6747843B2 (en) | 2002-03-26 | 2004-06-08 | Samsung Electronics Co., Ltd | Ramp design for reducing read-write head track positioning errors |
DE60326839D1 (de) | 2002-06-12 | 2009-05-07 | Genencor Int | Verfahren zur verbesserung einer bindungseigenschaft eines moleküls |
CA2488836A1 (en) | 2002-06-12 | 2003-12-24 | Genencor International, Inc. | Methods and compositions for milieu-dependent binding of a targeted agent to a target |
US7569673B2 (en) * | 2002-06-28 | 2009-08-04 | The United States Of America As Represented By The Department Of Health And Human Services | Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors |
WO2005021594A2 (en) * | 2003-08-29 | 2005-03-10 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use |
US20050084868A1 (en) | 2003-10-16 | 2005-04-21 | Wolfgang Aehle | Generation of stabilized proteins by combinatorial consensus mutagenesis |
-
2006
- 2006-04-21 US US11/885,492 patent/US8101728B2/en not_active Expired - Fee Related
- 2006-04-21 WO PCT/US2006/015082 patent/WO2006116076A2/en active Application Filing
- 2006-04-21 DK DK06769868.8T patent/DK1877102T3/da active
- 2006-04-21 JP JP2008508952A patent/JP5330826B2/ja not_active Expired - Fee Related
- 2006-04-21 EP EP06769868.8A patent/EP1877102B1/en not_active Not-in-force
-
2011
- 2011-12-12 US US13/323,291 patent/US8188240B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20090203104A1 (en) | 2009-08-13 |
US8101728B2 (en) | 2012-01-24 |
US8188240B2 (en) | 2012-05-29 |
EP1877102A2 (en) | 2008-01-16 |
EP1877102B1 (en) | 2014-05-07 |
US20120094357A1 (en) | 2012-04-19 |
JP2008539237A (ja) | 2008-11-13 |
JP5330826B2 (ja) | 2013-10-30 |
WO2006116076A2 (en) | 2006-11-02 |
WO2006116076A3 (en) | 2007-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301034I2 (nl) | romosozumab | |
NL300966I1 (nl) | caplacizumab | |
DK1838736T3 (da) | Cripto-bindende molekyler | |
ATE408603T1 (de) | Pyrazolylcarboxanilide | |
CR9974A (es) | Gavión | |
DE502006003394D1 (de) | Lehnenklappung | |
DE602006012066D1 (de) | Daraus | |
DE502006005667D1 (de) | Gelenklager | |
ATE549324T1 (de) | Tetrahydrobenzoxazine | |
DE502006005768D1 (de) | Hydrolysestabilisatorformulierungen | |
DE112006002964A5 (de) | Zweirichtungsreflektanzverteilungsmessgerät | |
DE502005005839D1 (de) | Feldgeerät | |
IS8666A (is) | Eingjafasamsetning | |
DE502006001397D1 (de) | Lagerbuchse | |
DE602006002046D1 (de) | Optometriegerät | |
DK1877102T3 (da) | Tab-molekyler | |
ATE485368T1 (de) | Hiv - impfung | |
DE502006004302D1 (de) | Verschlusskappe | |
SE0501828L (sv) | Rörelsetransformerande arrangemang | |
DE502006003147D1 (de) | Verbundgußplatte | |
DE502006001004D1 (de) | Hydrolager | |
DE102005052834B8 (de) | Punktschweißklebverbindung | |
DE502006003210D1 (de) | Nohydrogenpolysiloxanen | |
AT501523A3 (de) | Estrich | |
DE102006033170A8 (de) | Einfassnähmaschine |